跳至主要内容
临床试验/NCT03384108
NCT03384108招募中不适用

In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells in Healthy Subjects Using Stable Isotope Resolved Metabolomics: A Pilot Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
20
试验地点
1
主要终点
Percentage of enrichment of 13-Carbon molecules in the TCA cycle metabolites of plasma cells measured by gas chromatography mass spectrometry.

研究概览

简要总结

This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach

详细描述

Twenty healthy adult study participants between the ages of 18 and 60 years will be recruited to participate in this pilot study that will include two groups: a) Ex Vivo group (10 volunteers) and b) In Vivo group (10 volunteers). Volunteers will be recruited to either group in a sequential alternating fashion.

In vivo 13C SIRM studies evaluating the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18-60
  • Able to provide written consent

排除标准

  • Renal Failure
  • Pregnancy
  • Active steroid use
  • Active liver Disease
  • Anemia (Hemoglobin < 12.5 g/dL in men and < 11.5 g/dL in women)
  • H/O alcohol use (average > 2 drinks per day)
  • BMI > 30

研究组 & 干预措施

In Vivo

Experimental

Infusion of 5-13C-Glutamine intravenously in healthy subjects prior to undergoing a bone marrow aspiration.

干预措施: 5-13C-Glutamine (Other)

In Vivo

Experimental

Infusion of 5-13C-Glutamine intravenously in healthy subjects prior to undergoing a bone marrow aspiration.

干预措施: Bone marrow aspiration (Other)

Ex Vivo

Placebo Comparator

Healthy subjects will undergoing a bone marrow aspiration and then the plasma cells acquired will be cultured ex vivo in cell culture media containing 5-13C-Glutamine.

干预措施: Bone marrow aspiration (Other)

结局指标

主要结局

Percentage of enrichment of 13-Carbon molecules in the TCA cycle metabolites of plasma cells measured by gas chromatography mass spectrometry.

时间窗: Through study completion, an average of 1 hour

The plasma cells obtained from the bone marrow aspiration will be processed to determine the percent of 13-carbon enrichment in the various molecules of the TCA cycle within the plasma cells. The outcomes will be reported as a percentage. E.G. 5% of glutamine is labeled with 13-Carbon; e.g. 4% of glutamate is labeled with 13-carbon etc.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wilson I. Gonsalves, M.D.

Senior Associate Consultant

Mayo Clinic

研究点 (1)

Loading locations...

相似试验